- Home
- GCI vs KURA Comparison
GCI vs KURA Comparison
Compare GCI & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCI
- KURA
- Stock Information
- Founded
- GCI 1997
- KURA 2014
- Country
- GCI United States
- KURA United States
- Employees
- GCI N/A
- KURA N/A
- Industry
- GCI Newspapers/Magazines
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GCI Consumer Discretionary
- KURA Health Care
- Exchange
- GCI Nasdaq
- KURA Nasdaq
- Market Cap
- GCI 612.9M
- KURA 713.5M
- IPO Year
- GCI N/A
- KURA N/A
- Fundamental
- Price
- GCI $4.21
- KURA $8.38
- Analyst Decision
- GCI Buy
- KURA Buy
- Analyst Count
- GCI 3
- KURA 14
- Target Price
- GCI $5.70
- KURA $24.45
- AVG Volume (30 Days)
- GCI 1.4M
- KURA 2.0M
- Earning Date
- GCI 10-30-2025
- KURA 11-06-2025
- Dividend Yield
- GCI N/A
- KURA N/A
- EPS Growth
- GCI N/A
- KURA N/A
- EPS
- GCI 0.73
- KURA N/A
- Revenue
- GCI $2,390,148,000.00
- KURA $83,279,000.00
- Revenue This Year
- GCI N/A
- KURA $60.25
- Revenue Next Year
- GCI N/A
- KURA $155.10
- P/E Ratio
- GCI $5.89
- KURA N/A
- Revenue Growth
- GCI N/A
- KURA N/A
- 52 Week Low
- GCI $2.55
- KURA $5.41
- 52 Week High
- GCI $5.93
- KURA $21.40
- Technical
- Relative Strength Index (RSI)
- GCI 55.29
- KURA 62.01
- Support Level
- GCI $4.02
- KURA $8.13
- Resistance Level
- GCI $4.31
- KURA $8.90
- Average True Range (ATR)
- GCI 0.14
- KURA 0.50
- MACD
- GCI -0.00
- KURA 0.02
- Stochastic Oscillator
- GCI 72.86
- KURA 63.56
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.